Clathrin light chain‐conjugated drug delivery for cancer

Targeted drug delivery systems hold the remarkable potential to improve the therapeutic index of anticancer medications markedly. Here, we report a targeted delivery platform for cancer treatment using clathrin light chain (CLC)‐conjugated drugs. We conjugated CLC to paclitaxel (PTX) through a gluta...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Sungwook, Jiang, Liwei, Zhao, Jing, Shultz, Leonard D., Greiner, Dale L., Bae, Munhyung, Li, Xiaofei, Ordikhani, Farideh, Kuai, Rui, Joseph, John, Kasinath, Vivek, Elmaleh, David R., Abdi, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842032/
https://www.ncbi.nlm.nih.gov/pubmed/36684105
http://dx.doi.org/10.1002/btm2.10273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842032/
https://www.ncbi.nlm.nih.gov/pubmed/36684105
http://dx.doi.org/10.1002/btm2.10273

Ejemplares similares